116 related articles for article (PubMed ID: 11921270)
21. Therapy-related myelodysplastic syndrome with trisomy 1q due to der(1;7) and megakaryoblastic proliferation developing during complete remission of therapy-related acute myeloid leukemia with t(8;21).
Sakai C; Matsubayashi K; Saotome T; Ishii A; Kumagai K
Intern Med; 2004 Jul; 43(7):582-6. PubMed ID: 15335185
[TBL] [Abstract][Full Text] [Related]
22. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
Arana-Yi C; Block AW; Sait SN; Ford LA; Barcos M; Baer MR
Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome.
Lyman GH; Kuderer NM
Cancer Treat Res; 2011; 157():167-78. PubMed ID: 21052956
[No Abstract] [Full Text] [Related]
24. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms.
Tang G; Wang SA; Lu V; Lee HC; Qazilbash MH; Wang XI; Yin CC; Orlowski R; Wang Y; Patel A; Medeiros LJ; Lu G
Leuk Res; 2014 Aug; 38(8):896-900. PubMed ID: 24939217
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia with complex cytogenetic abnormalities associated with long-term use of oral colloidal silver as nutritional supplement - Case report and review of literature.
Keung YK; Wang T; Hong-Lung Hu E
J Oncol Pharm Pract; 2020 Jan; 26(1):212-215. PubMed ID: 30854923
[TBL] [Abstract][Full Text] [Related]
26. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
27. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.
Rödjer S; Swolin B; Weinfeld A; Westin J
Cancer Genet Cytogenet; 1990 Aug; 48(1):67-73. PubMed ID: 2372790
[TBL] [Abstract][Full Text] [Related]
29. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
[TBL] [Abstract][Full Text] [Related]
30. Therapy-related myelodysplastic syndromes.
Park DJ; Koeffler HP
Semin Hematol; 1996 Jul; 33(3):256-73. PubMed ID: 8819235
[No Abstract] [Full Text] [Related]
31. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
[No Abstract] [Full Text] [Related]
32. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
[No Abstract] [Full Text] [Related]
33. Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis.
Gertz MA; Kyle RA
Arch Intern Med; 1990 Mar; 150(3):629-33. PubMed ID: 2310282
[TBL] [Abstract][Full Text] [Related]
34. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Ballen KK; Antin JH
Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
[TBL] [Abstract][Full Text] [Related]
35. Development of myelodysplastic syndrome evolving to acute myeloid leukemia in a patient receiving etanercept for psoriasis.
Knudson RM; Tefferi A; Pittelkow MR; Davis MDP
J Am Acad Dermatol; 2011 Sep; 65(3):673-674. PubMed ID: 21839334
[No Abstract] [Full Text] [Related]
36. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.
Cortes J; O'Brien S; Kantarjian H; Cork A; Stass S; Freireich EJ; Keating M; Pierce S; Estey E
Leukemia; 1994 Dec; 8(12):2174-8. PubMed ID: 7808007
[TBL] [Abstract][Full Text] [Related]
37. Chromosome abnormalities in myelodysplastic syndromes.
Nowell PC
Semin Oncol; 1992 Feb; 19(1):25-33. PubMed ID: 1736367
[No Abstract] [Full Text] [Related]
38. Double therapy-related leukemia: coincidental occurrence or susceptibility for leukemia?
Horiike S
Intern Med; 2004 Jul; 43(7):531-2. PubMed ID: 15335174
[No Abstract] [Full Text] [Related]
39. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia presenting with cutaneous infiltrates in a patient receiving etanercept for chronic lymphocytic vasculitis.
Sadlier M; Connaghan G; Kirby B
J Am Acad Dermatol; 2012 Dec; 67(6):e264-5. PubMed ID: 23158628
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
